1 Min Read
Feb 7 (Reuters) - FOLLICUM AB:
* FOLLICUM PHASE IIA STUDY OF FOL-005 AGAINST HAIR LOSS APPROVED BY THE GERMAN MEDICINES AGENCY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.